Eric Pauwels
Chief Business Officer at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,71173,411 held (−5%) | $75.00 | $278K | -13.7% |
| Jun 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 17,56673,411 held (−19%) | $75.00 | $1.3M | -13.7% |
| Feb 20SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,01977,122 held (−4%) | $69.36 | $209K | -6.7% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,56184,928 held (−3%) | $76.42 | $196K | -15.3% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 58784,341 held (−1%) | $76.98 | $45K | -16.0% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,45482,887 held (−2%) | $76.45 | $111K | -15.4% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,72281,165 held (−2%) | $77.41 | $133K | -16.4% |
| Jan 12SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,02480,141 held (−1%) | $78.70 | $81K | -17.8% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,78988,841 held (−2%) | $76.95 | $138K | -15.9% |
| Jan 8SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,35287,489 held (−2%) | $77.48 | $105K | -16.5% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3770,474 held (−0%) | $75.66 | $3K | -14.5% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4270,432 held (−0%) | $77.26 | $3K | -16.3% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5970,373 held (−0%) | $78.01 | $5K | -17.1% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 19370,745 held (−0%) | $75.45 | $15K | -14.2% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 31370,432 held (−0%) | $77.73 | $24K | -16.8% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5970,373 held (−0%) | $78.43 | $5K | -17.5% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,50088,678 held (−2%) | $75.77 | $114K | -14.6% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 4,53784,141 held (−5%) | $76.33 | $346K | -15.2% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10,54873,593 held (−13%) | $77.55 | $818K | -16.6% |
| Dec 23SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,22070,373 held (−4%) | $78.33 | $252K | -17.4% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 1,24572,912 held (−2%) | $75.28 | $94K | -14.1% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 3,58470,473 held (−5%) | $75.31 | $270K | -14.1% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10070,373 held (−0%) | $76.00 | $8K | -14.9% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 35,26170,473 held (−33%) | $75.44 | $2.7M | -14.2% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10070,373 held (−0%) | $76.00 | $8K | -14.9% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 12070,373 held (−0%) | $75.02 | $9K | -13.8% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 25170,373 held (−0%) | $75.00 | $19K | -13.7% |
| Dec 19SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 2,83170,373 held (−4%) | $75.07 | $213K | -13.8% |
- Sell
Chief Business Officer Eric Pauwels sold $278K of PTCT at $75.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Eric Pauwels sold $1.3M of PTCT at $75.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Eric Pauwels sold $209K of PTCT at $69.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Eric Pauwels sold $196K of PTCT at $76.42 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Eric Pauwels sold $45K of PTCT at $76.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Business Officer Eric Pauwels sold $111K of PTCT at $76.45 — pre-scheduled 10b5-1 plan sale.